OraSure Technologies, Inc.

NASDAQ:OSUR

Medical - Instruments & Supplies

Healthcare
$3.59 -3.47%

-$0.16 today

Market cap
$247.88M
Beta
1.01
P/E (TTM)
-4.0
EPS (TTM)
-$1.08
52W Low $2.08High $4.58

Volume 0.49M

Average 0.61M

OSUR Accumulated OCI

Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.

OraSure Technologies, Inc.NASDAQ: OSUR

Accumulated OCI · Q1 FY2026 · quarter ended Mar 2026

Accumulated OCI remains negative

Q1 FY2026 Accumulated OCI was -$20.04M, compared with -$24.12M a year earlier.

Context

  • Accumulated OCI amounted to 5.3% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Accumulated OCI grew in size in 1 of the last 3 fiscal years.

What to watch

Whether Accumulated OCI keeps rising in the next quarterly balance sheet after a +16.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$20.04M-8.9% QoQ
Last fiscal yearDec 2025
-$18.4M+24.4% YoY
Year agoMar 2025
-$24.12M+16.9% since
Accumulated OCI past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+16.9%——
1 year+24.4%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accumulated OCI history

USD · from the balance sheet

Latest · FY2025
(18.4M) USD
Year-over-year change
+24.4%

Accumulated OCI vs competitors

How OSUR compares with its peers on the latest reported figures

  • Peers report in different currencies, so Accumulated OCI is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +16.9% is the 3rd highest of 8, against a peer median of -24.7%.
  • Accumulated OCI amounts to 5.3% of total assets for OSUR, versus a peer median of 0.2%.
OSUR Competitors
Accumulated OCI for OSUR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PREPrenetics Global LimitedMar 2026$121.09M USD-24.7%—69.1%
NYXHNyxoah S.A.Mar 2026€13.9M EUR+1424.0%+325.0%14.2%
PROFProfound Medical Corp.Mar 2026$4.03M USD+41.8%-25.8%5.5%
NTHINeonc Technologies Holdings, Inc.Mar 2026$0 USD——0.0%
STIMNeuronetics, Inc.Mar 2026$0 USD——0.0%
NAUTNautilus Biotechnology, Inc.Mar 2026-$91K USD-148.1%—0.1%
CATXPerspective Therapeutics, Inc.Mar 2026-$226K USD-1289.5%—0.1%
TARAProtara Therapeutics, Inc.Mar 2026-$364K USD-509.0%—0.2%
UTMDUtah Medical Products, Inc.Mar 2026-$9.92M USD+11.4%—8.0%
OSUROraSure Technologies, Inc.Mar 2026-$20.04M USD+16.9%—5.3%
Peer median (excluding OSUR) —-24.7%+149.6%0.2%

Competitors are the stored peer set for OSUR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents116.76M83.98M290.41M267.76M199.28M
Short-term Investments36.28M26.87M000
Net Receivables45.32M70.8M40.17M23.82M22.2M
Inventory53.14M95.7M47.61M34.2M31.06M
Other Current Assets39.87M41.57M2.23M3.49M4.15M
Total Current Assets299.31M325.19M386.46M333.22M261.91M
Property, Plant & Equipment (Net)84.98M71.11M58.27M58.69M51.32M
Goodwill40.28M35.1M35.7M40.33M43.36M
Intangible Assets14.34M11.69M1.21M17.44M19.05M
Long-term Investments17.01M0028.3M25.96M
Tax Assets000156K271K
Other Non-current Assets5.07M1.09M1.22M1.53M1.3M
Total Non-current Assets161.68M118.99M96.39M146.44M141.26M
Total Assets460.99M444.18M482.85M479.66M403.17M
Account Payables28.02M38.02M13.15M8.17M6.52M
Short-term Debt00000
Tax Payables2.23M1.52M1.25M1.34M0
Deferred Revenue2.94M2.27M1.56M2.96M1.52M
Other Current Liabilities4.75M5.52M3.98M5.22M21.18M
Total Current Liabilities68.06M69.06M39.54M33.48M39.8M
Long-term Debt00000
Deferred Tax Liabilities2.23M408K554K00
Deferred Revenue (Non-current)00000
Other Non-current Liabilities1.01M680K696K23.4M11.58M
Total Non-current Liabilities12.39M10.69M12.64M35.84M22.55M
Total Liabilities80.46M79.76M52.17M69.32M62.34M
Common Stock00000
Retained Earnings(120.45M)(137.59M)(83.93M)(103.43M)(172.16M)
Accumulated OCI(10.08M)(18.44M)(14.94M)(24.36M)(18.4M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity380.53M364.43M430.67M410.34M340.83M
Total Debt12.27M12.55M13.5M14.6M13.2M
Net Debt(104.49M)(71.43M)(276.9M)(253.16M)(186.08M)

OraSure Technologies, Inc.

NASDAQ:OSUR

Intrinsic Alpha fair value

Locked

Current Price

$3.59

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.